Microbot Medical announced that it raised nearly $9 million in a common stock offering, days after announcing that it is set to unveil its disposable robotic system for multiple procedures later this month. The Hingham, Mass.–based company agreed to sell 900,901 shares of common stock at a purchase price of $11.10 per share. The gross […]
Microbot Medical
StemCells soars 600% on reverse merger with Israel’s Microbot Medical
Shares in StemCells (NSDQ:STEM) initially soared some 600% this week after the company initiated a reverse merger with Microbot Medical, after the failure of a Phase II trial of StemCells’ spinal cord injury treatment. The merger also saw the resignation of CEO Ian Massey, CFO Gregory Schiffman and a trio of board members, as the team led by […]
